The electrosurgical devices market comprises essential electrosurgical equipment used in surgical procedures including electrosurgical generators, electrosurgical instruments and accessories, and electrosurgical electrodes. Electrosurgical devices utilize high-frequency electrical current to cut, coagulate, desiccate, and fulgurate tissue. These procedures help reduce blood loss during surgeries, thereby enabling faster recovery for patients. The growing volume of general surgical procedures such as hernia repair, appendicitis, cholecystectomies, and growing cancer incidence resulting in increased demand for ablation and resection procedures are major factors spurring demand for electrosurgical devices.
The Global electrosurgical devices market is estimated to be valued at US$ 6,892.4 Mn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the electrosurgical devices are Bovie Medical Corporation, Medtronic Plc, BOWA-Electronic GmbH & Co. KG, KLS Martin, B. Braun Melsungen AG, Conmed, Olympus Corp., Boston Scientific Corporation, Erbe Elektromedizin GmbH, Symmetry Surgical Inc., Encision Inc., Gala Therapeutics, Inc., Apyx Medical Corporation, and Johnson & Johnson Services, Inc. These key players are focusing on new product development and launches to strengthen their market position. For instance, in 2022, Medtronic launched the Valleylab FT10 and FT10X electrosurgical generators in the US and select international markets.
The key opportunities in the electrosurgical devices market include rising demand for minimally invasive surgeries due to advantages such as reduced pain, scarring and faster recovery times. Furthermore, increasing focus on ambulatory surgical centers especially in developing countries of Asia Pacific and Latin America is anticipated to present lucrative growth opportunities for players in the electrosurgical devices market.
Globally, the electrosurgical devices market is consolidated in nature with key players focusing on geographical expansion strategies to strengthen their foothold. For instance, in 2022, Olympus Corp expanded its electrosurgical device portfolio in the US market with the launch of the ESG-150 Electrosurgical Generator.
Market Drivers
Technological advancements leading to launch of advanced bipolar and monopolar devices with enhanced safety, efficiency and precision are expected to drive the growth of electrosurgical devices market. These advanced devices minimize collateral thermal damage to surrounding tissues during precise dissection and sealing. For instance, launch of Erbe VIO 300D electrosurgical generator with Argon Plasma Coagulation (APC) probe enables safe and effective treatment of bleeding lesions.
Market Restrain
High risk of surgical site infections associated with electrosurgical procedures is a major challenge hampering market growth. Use of electrosurgical devices causes thermal injuries to tissues which delay wound healing and increases risk of surgical site infections. Stringent regulatory norms regarding safety and efficacy of these devices also poses significant restrain.
Segment Analysis
The electrosurgical devices market is dominated by electrosurgery generators sub segment. Electrosurgery generators are devices that provide high-frequency alternating current to electrosurgical instruments used for cutting, coagulation, and desiccation of tissue. Advancements in electrosurgery generator designs have enabled them to deliver current appropriate for various surgical applications with minimal variation. This has elevated their demand across diverse surgical procedures including general surgery, gynecology, urology, and others.
The active electrodes sub segment is expected to witness the highest growth during the forecast period. Active electrodes are handheld devices that transfer radiofrequency or microwave energy from electrosurgical generators to tissues. Technological developments in active electrode designs focusing on enhanced precision and control have boosted their adoption. Further, growing preference for minimally invasive surgeries is augmenting the demand for advanced bipolar and monopolar active electrodes.
Global Analysis
North America currently dominates the electrosurgical devices market and is likely to continue its dominance during the forecast period. High healthcare spending, well-developed medical technology infrastructure, and greater preference for minimally invasive procedures are some key factors driving the regional market. Asia Pacific is projected to be the fastest-growing regional market between 2023 and 2030. Rapidly developing healthcare infrastructure along with growing medical tourism are fueling the demand for electrosurgical devices in Asia Pacific countries like India and China. Additionally, supportive government initiatives for modernizing healthcare systems are also boosting market growth in the region. Europe has considerable market share due to increasing geriatric population and chronic disease burden. Regulatory approval processes for medical devices are comparatively lenient in Europe, allowing faster launch of technologically advanced electrosurgical products.
Comments
0 comment